NCT00901771已完成不适用
A Non-randomized, Case Series Study of the Effectiveness of Provent Treatment of Obstructive Sleep Apnea Patients Who Are Non-compliant or Minimally Adherent With Positive Airway Pressure Therapy
St. Luke's Hospital, Chesterfield, Missouri2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年5月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Week 1 AHI as compared to Screening/Baseline AHI
研究概览
简要总结
The primary objective of the proposed investigation is to evaluate the efficacy of the Provent device in a sample of OSA patients who have either refused or been non-adherent with PAP treatment. Both initial efficacy (evaluated after approximately one week with Provent) and efficacy after approximately 5 weeks in patients who demonstrate initial efficacy will be assessed. A secondary objective is to assess adherence with Provent treatment during the 5-week evaluation period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Current signs and symptoms consistent with a diagnosis of OSA in the opinion of the study physician
- •Rejection of PAP treatment or minimally adherent with PAP treatment
- •Use of the Provent device for a specified amount of time each night during three consecutive nights of the trial period
- •AHI > 15, or AHI > 10 with evidence of CMS-recognized symptoms or co- morbidities, on screening/baseline PSG
- •Investigator believes that subject can benefit from OSA treatment
- •Subject understands and is willing and able to comply with study requirements
排除标准
- •Use of any device that interferes with nasal or oral breathing
- •Persistent blockage of one or both nostrils which prevents airflow in one or both nostrils
- •Any chronic sores or lesions on the inside or outside of the nose
- •Chronic use of nasal decongestants other than nasal steroids
- •History of allergic reaction to acrylic-based adhesives (such as those found in BAND-AIDS®)
- •Current acute upper respiratory (including nasal, sinus, or middle ear) inflammation or infection or perforation of the tympanic membrane (may be re-considered for participation after the acute episode resolves)
- •History of frequent and/or poorly treated severe nasal allergies or sinusitis which may interfere with the ability to use Provent
- •Severe respiratory disorders (including respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastinum, etc.).
- •Pathologically low blood pressure.
- •Narcolepsy, idiopathic hypersomnolence, chronic insomnia, restless legs syndrome, REM sleep behavior disorder or any other diagnosed or suspected sleep disorder other than OSA that could affect the likelihood of apneas/hypopneas during a PSG.
- •Periodic limb movement arousal index (PLMAI) > 10 on the screening/baseline PSG.
- •Current use of diurnal or nocturnal supplemental oxygen
- •Currently working night or rotating shifts
- •Consumption of > 10 caffeinated beverages per day (approximately 1000 mg per day)
- •History of severe cardiovascular disease, including New York Heart Association Class III or IV heart failure, coronary artery disease with angina or myocardial infarction in the past 6 months, stroke in the past 6 months
- •History of cardiac rhythm disturbance (defined as a 5-beat run of sustained ventricular tachycardia or bradycardia if < 30 beats per min for a 10-second run or previously undiagnosed and untreated atrial fibrillation or Mobitz II or third-degree heart block)
- •Current psychiatric disorder with psychotic features.
- •Pregnant or trying to become pregnant
结局指标
主要结局
Week 1 AHI as compared to Screening/Baseline AHI
时间窗: 1 week
次要结局
- Week 5 AHI as compared to Screening/Baseline AHI(5 weeks)
- Minutes with SaO2 <90%: Week 5 vs. Screening/Baseline(5 weeks)
- Epworth Sleepiness Scale: Week 5 vs. Baseline(5 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral RhinosinusitisAcute RhinosinusitisNCT03480100Bitop AG120
已完成
不适用
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric CancerStomach NeoplasmsNCT05334719Bristol-Myers Squibb500
已完成
不适用
A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in GreeceAdvanced Soft Tissue SarcomaNCT02618122Genesis Pharma S.A.63
已完成
不适用
Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life SettingNon-Hodgkin's LymphomaNCT02199288Hoffmann-La Roche54
已完成
不适用
An prospective interventional study of the incidence and severity of hypoxia in Paediatric anaesthetic care unit (PACU) using Hudson mask and heated humidified high flow nasal cannula oxygen therapy (HHHFNC)HypoxiaAnaesthesiology - AnaestheticsACTRN12616001658404niversity of Auckland1,706